Posts about

hemato-oncology

SOCIAL MEDIA INSIGHTS - 2022 ASCO ANNUAL MEETING

Digital, hemato-oncology, Social Media Listening, Oncology

The American Society of Clinical Oncology (ASCO) annual meeting is a flagship event in the global...

Social Media insights - 2021 ASCO annual meeting

Digital, hemato-oncology, Social Media Listening, Oncology

The American Society of Clinical Oncology (ASCO) annual meeting is a flagship event in the global...

MDS: Treatment paradigms are changing

hemato-oncology, Tracking Studies, Syndicated Studies, Oncology

MyeloDysplastic Syndromes: our syndicated research will tell you why - and how - treatment...

Social Media Insights: ASCO 2020 Part 2

hemato-oncology, Social Media Listening, Oncology

The American Society of Oncologists (ASCO) annual meeting is a major fixture in the global oncology 

DLBCL Patient Insights in the US and EU5

hemato-oncology, Tracking Studies, DLBCL market, Syndicated Studies

When working on a new or existing brand within the DLBCL market it's important to have up to date...

Social Media Insights: ASCO 2020 Part 1

hemato-oncology, Social Media Listening, Oncology

The American Society of Oncologists (ASCO) annual meeting is a major fixture in the global oncology 

Social Media Listening: Insights from Healthcare conferences

Market Research Industry, hemato-oncology, Social Media Listening, Oncology

Healthcare conferences provide unique opportunities to gain first-hand insights from otherwise...

DLBCL Treatment Performance in EU5 and US

hemato-oncology, Tracking Studies, DLBCL market, Syndicated Studies

The DLBCL market is undergoing a period of change, and the relative performance of the various...

DLBCL Market Overview

hemato-oncology, Tracking Studies, DLBCL market, Syndicated Studies, Oncology

Following the release of our latest ebook, this is the first blog post in this series focusing on...

New AplusA eBook Covers the DLBCL Market

AplusA News, hemato-oncology, Tracking Studies, DLBCL market, Syndicated Studies, Oncology

Introducing the latest eBook in AplusA's Hemato-Oncology series